June 2026 in “Dermatology and Therapy” This study reported that ritlecitinib was prescribed to a diverse group of patients with severe alopecia areata in the first 10 months after FDA approval, indicating its potential role in AA management.
April 2026 in “Frontiers in Pharmacology” This study suggests that nanotechnology-based drug delivery systems can improve the targeted, sustained delivery and stability of dermatological treatments, potentially leading to better outcomes and reduced side effects for various aesthetic skin conditions, though further clinical trials are needed to confirm these benefits.
February 2026 in “Journal of Drugs in Dermatology” This systematic review discusses various topical, oral, injectable, and non-pharmacological treatments for androgenetic alopecia, examining both current and emerging therapeutic options in addressing this common form of hair loss.
February 2026 in “Trends in Sciences” In a testosterone-induced mouse model, this study found that exosomes from injectable Platelet-Rich Fibrin (i-PRF) significantly reduced inflammation, oxidative stress, and apoptosis, while enhancing hair regeneration, with the greatest improvements seen when combined with minoxidil, suggesting potential as a novel treatment for androgenetic alopecia.
July 2025 in “Journal of Clinical Medicine” In this review, platelet concentrates were found to show comparable efficacy to steroids and immunosuppressive drugs in treating oral lichen planus, with some studies reporting more benefits and others noting more severe adverse reactions with platelet treatments.
June 2025 in “ACS Biomaterials Science & Engineering” In this study, researchers developed a new microneedle patch delivery system for minoxidil, which enhanced its controlled release and improved hair growth in mice, potentially offering better treatment outcomes for androgenetic alopecia.
March 2025 in “International Journal of Trichology” In this study, researchers found that storing hair grafts at 37°C with 10% DMEM led to better graft survival compared to other solutions and temperatures, suggesting this method may enhance graft longevity and therapeutic outcomes.
October 2024 in “Journal of the Endocrine Society” In this retrospective chart review, researchers observed that estrogen monotherapy effectively suppressed testosterone levels below 50ng/dL in all transfeminine patients studied, particularly those using injectable formulations, though the small sample size and ongoing data collection limit these findings.
October 2024 in “Journal of the Endocrine Society” In this retrospective study, among transfeminine patients aged 19-81 receiving gender-affirming estrogen therapy, 100% achieved testosterone suppression without anti-androgens when serum estradiol exceeded 100pg/mL, predominantly using injectable estrogen.
October 2024 in “A I Burnasyan Federal Medical Biophysical Center Clinical Bulletin” This literature review on androgenetic alopecia highlights its significant impact on patients' mental health and quality of life and discusses various treatment pathways, including topical, systemic, and surgical interventions, while emphasizing the need for continued research to develop effective therapies.
December 2023 in “Lasers in Medical Science” Fractionated laser therapy, especially erbium-glass laser, effectively increases hair thickness in people with hair loss but doesn't increase the number of hairs.
July 2023 in “Research Square (Research Square)” In an in-vitro study, researchers found that a specific concentration of Aloe Vera combined with injectable platelet-rich fibrin (i-PRF) significantly increased hair follicle stem cell proliferation compared to Aloe Vera or i-PRF alone, indicating potential benefits for alopecia treatment.
April 2022 in “DOAJ (DOAJ: Directory of Open Access Journals)” This article reviews evidence-based complementary strategies to enhance hair regrowth after post-COVID-19 telogen effluvium, emphasizing psychological support, patient education, nutrition, and both topical and injectable hair growth stimulators.
January 2022 in “Clinical Cases in Dermatology” This review discusses prevention, diagnosis, and treatment strategies for traction alopecia but presents no new clinical findings; the authors emphasize early intervention to prevent permanent hair loss.
January 2020 in “Hair transplant forum international” This review discusses exosomal micro RNAs from dermal papilla cells in hair follicle mediation and reports no new clinical results.
February 2019 in “Dermatologic Surgery” This overview discusses the Dermatologic Surgery journal, which provides comprehensive coverage of cosmetic and reconstructive skin surgery and reports no new clinical results.
January 2019 in “Dermatologic Surgery” This abstract introduces the Dermatologic Surgery journal as a leading source of comprehensive and up-to-date information on cosmetic and reconstructive skin surgery and skin cancer. It highlights the journal's wide range of peer-reviewed content, making it essential reading for professionals in dermatology and related fields.
July 2018 in “Dermatologic Surgery” This overview describes the content and scope of the Dermatologic Surgery journal, which includes a wide range of information on cosmetic and reconstructive skin surgeries but reports no new research results.
This review identifies headache, hypertrichosis, and allergy as potential side effects of Minoxidil treatment for hair loss, based on only two studies that met inclusion criteria.
August 2010 in “Springer eBooks” Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.
January 2009 in “Oral and Maxillofacial Surgery Clinics of North America” The document concludes that understanding risks, careful patient selection, precise surgery, quick complication management, and good communication can improve cosmetic facial surgery outcomes.
This study found that an injectable hair material showed good biocompatibility in micropigs and effectively promoted dermal thickening, suggesting its potential as a new soft tissue filler.
September 1986 in “Journal of the American Academy of Dermatology” This conference summary covers advancements in dermatology, including aging skin and acne therapies, but reports no new experimental results.
February 2026 in “Figshare” In this study, researchers developed a biocompatible, ROS-responsive hydrogel to deliver miR-665 locally, effectively reducing inflammatory signaling and promoting hair follicle regeneration in an alopecia areata mouse model, offering a promising approach for targeted treatment.
February 2026 in “Figshare” This study found that a newly developed biocompatible hydrogel, responsive to reactive oxygen species, enabled targeted delivery of miR-665, significantly promoting hair regeneration and reducing T-cell infiltration in a mouse model of alopecia areata, suggesting a promising strategy for treating this condition.
November 2025 in “Yemeni Journal For Medical Sciences” This study assessed contraceptive use among women in Mukalla city, Yemen, reporting that 78.7% experienced side effects such as hair loss and abnormal bleeding, with oral contraceptive pills being the most common method.
July 2025 in “International Journal of Trichology” This source discusses the ethical dilemmas and business pressures in cosmetic dermatology, emphasizing the shift toward commercialism and profit-driven practices influenced by social media and market demands, potentially leading to conflicts of interest and professional misconduct.
December 2017 in “Journal of Aesthetic Nursing” This article discusses misconceptions surrounding level 7 qualifications in aesthetic training and emphasizes the importance of selecting reputable training providers, without presenting new research results.
August 2023 in “Journal of Student Research” This paper discusses the non-curable nature of alopecia and explores various treatments, their side effects, cost, and effectiveness, while also examining how diet, COVID-19, and the COVID-19 vaccine may affect the condition.
July 2008 in “Facial Plastic Surgery Clinics of North America” Men's facial rejuvenation involves unique challenges and is increasingly popular, with many opting for nonsurgical treatments.